177 related articles for article (PubMed ID: 37879188)
1. A supramolecular polymer-collagen microparticle slurry for bone regeneration with minimal growth factor.
McClendon MT; Ji W; Greene AC; Sai H; Sangji MH; Sather NA; Chen CH; Lee SS; Katchko K; Jeong SS; Kannan A; Weiner J; Cook R; Driscoll A; Lubbe R; Chang K; Haleem M; Chen F; Qiu R; Chun D; Stock SR; Hsu WK; Hsu EL; Stupp SI
Biomaterials; 2023 Nov; 302():122357. PubMed ID: 37879188
[TBL] [Abstract][Full Text] [Related]
2. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived mesenchymal stem cells assembled with low-dose BMP-2 in a three-dimensional hybrid construct enhances posterolateral spinal fusion in syngeneic rats.
Hu T; Abbah SA; Toh SY; Wang M; Lam RW; Naidu M; Bhakta G; Cool SM; Bhakoo K; Li J; Goh JC; Wong HK
Spine J; 2015 Dec; 15(12):2552-63. PubMed ID: 26342750
[TBL] [Abstract][Full Text] [Related]
5. Bone Regeneration by Controlled Release of Bone Morphogenetic Protein-2: A Rabbit Spinal Fusion Chamber Molecular Study.
Hu T; Naidu M; Yang Z; Lam WM; Kumarsing RA; Ren X; Ng F; Wang M; Liu L; Tan KC; Kwok KT; Goodman SB; Goh JC; Wong HK
Tissue Eng Part A; 2019 Oct; 25(19-20):1356-1368. PubMed ID: 30727849
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
[TBL] [Abstract][Full Text] [Related]
7. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
8. The bone morphogenetic protein-2/7 heterodimer is a stronger inducer of bone regeneration than the individual homodimers in a rat spinal fusion model.
Morimoto T; Kaito T; Matsuo Y; Sugiura T; Kashii M; Makino T; Iwasaki M; Yoshikawa H
Spine J; 2015 Jun; 15(6):1379-90. PubMed ID: 25733023
[TBL] [Abstract][Full Text] [Related]
9. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model.
Liao SS; Guan K; Cui FZ; Shi SS; Sun TS
Spine (Phila Pa 1976); 2003 Sep; 28(17):1954-60. PubMed ID: 12973141
[TBL] [Abstract][Full Text] [Related]
10. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
11. Preparation of Coralline Hydroxyapatite Implant with Recombinant Human Bone Morphogenetic Protein-2-Loaded Chitosan Nanospheres and Its Osteogenic Efficacy.
Xia YJ; Wang W; Xia H; Huang XH; Deng FP; Ying QS; Yu X; Li LH; Wang JH; Zhang Y
Orthop Surg; 2020 Dec; 12(6):1947-1953. PubMed ID: 33080108
[TBL] [Abstract][Full Text] [Related]
12. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
[TBL] [Abstract][Full Text] [Related]
13. A novel nano-hydroxyapatite/synthetic polymer/bone morphogenetic protein-2 composite for efficient bone regeneration.
Bal Z; Korkusuz F; Ishiguro H; Okada R; Kushioka J; Chijimatsu R; Kodama J; Tateiwa D; Ukon Y; Nakagawa S; Dede EÇ; Gizer M; Korkusuz P; Yoshikawa H; Kaito T
Spine J; 2021 May; 21(5):865-873. PubMed ID: 33493682
[TBL] [Abstract][Full Text] [Related]
14. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold-based spinal fusion in a porcine model.
Hu T; Liu L; Lam RWM; Toh SY; Abbah SA; Wang M; Ramruttun AK; Bhakoo K; Cool S; Li J; Cho-Hong Goh J; Wong HK
J Tissue Eng Regen Med; 2022 Jan; 16(1):63-75. PubMed ID: 34687157
[TBL] [Abstract][Full Text] [Related]
16. The Effects of High-Dose Parathyroid Hormone Treatment on Fusion Outcomes in a Rabbit Model of Posterolateral Lumbar Spinal Fusion Alone and in Combination with Bone Morphogenetic Protein 2 Treatment.
Holmes CA; Ishida W; Elder BD; Lo SL; Chen YA; Kim E; Locke J; Taylor M; Witham TF
World Neurosurg; 2018 Jul; 115():e366-e374. PubMed ID: 29678698
[TBL] [Abstract][Full Text] [Related]
17. Competitive Protein Binding Influences Heparin-Based Modulation of Spatial Growth Factor Delivery for Bone Regeneration.
Hettiaratchi MH; Chou C; Servies N; Smeekens JM; Cheng A; Esancy C; Wu R; McDevitt TC; Guldberg RE; Krishnan L
Tissue Eng Part A; 2017 Jul; 23(13-14):683-695. PubMed ID: 28338419
[TBL] [Abstract][Full Text] [Related]
18. Sustained delivery of a heterodimer bone morphogenetic protein-2/7 via a collagen hydroxyapatite scaffold accelerates and improves critical femoral defect healing.
Liu Y; Puthia M; Sheehy EJ; Ambite I; Petrlova J; Prithviraj S; Oxborg MW; Sebastian S; Vater C; Zwingenberger S; Struglics A; Bourgine PE; O'Brien FJ; Raina DB
Acta Biomater; 2023 May; 162():164-181. PubMed ID: 36967054
[TBL] [Abstract][Full Text] [Related]
19. Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion.
Cottrill E; Pennington Z; Wolf MT; Dirckx N; Ehresman J; Perdomo-Pantoja A; Rajkovic C; Lin J; Maestas DR; Mageau A; Lambrechts D; Stewart V; Sciubba DM; Theodore N; Elisseeff JH; Witham T
J Neurosurg Spine; 2023 Jul; 39(1):113-121. PubMed ID: 37021767
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-2 application by a poly(D,L-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors.
Kandziora F; Bail H; Schmidmaier G; Schollmeier G; Scholz M; Knispel C; Hiller T; Pflugmacher R; Mittlmeier T; Raschke M; Haas NP
J Neurosurg; 2002 Jul; 97(1 Suppl):40-8. PubMed ID: 12120650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
